CervoMed Inc — Quarterly Financial Statistics (NASDAQ:CRVO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -8.05 M-3.89 M-6.51 M-6.47 M-6.58 M -23.45 M Cash from investing activities 9.31 M5.4 M-254.99 K7.58 M5.37 M 18.1 M Cash from financing activities 0——00 — Free cash flow -8.05 M-3.89 M-6.51 M-6.47 M-6.58 M -23.45 M

News

H.C. Wainwright reiterates CervoMed stock rating on conference data

CervoMed Inc. (CRVO) Reports Q4 Loss, Lags Revenue Estimates

Buy 2 ‘Strong Buy’ Biotech Stocks With 400%+ Upside, According to Wall Street - TipRanks.com

CervoMed sets 50mg dose for phase 3 dementia trial

Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards?

CervoMed’s neflamapimod selected for UK ALS trial platform

Cantor Fitzgerald initiates CervoMed stock with Overweight rating

CervoMed’s DLB drug shows promise in phase 2b trial

CervoMed stock soars after promising dementia drug trial results

Neflamapimod reduces key neurodegeneration markers in DLB study

CervoMed Inc. (CRVO) Reports Q3 Loss, Misses Revenue Estimates

Atara Biotherapeutics (ATRA) Surges 10.0%: Is This an Indication of Further Gains?